Literature DB >> 29604376

Identification and characterization of potential bioactive compounds from the leaves of Leucosidea sericea.

Srinivasa C Pendota1, Adeyemi O Aremu1, Lenka Poštová Slavětínská2, Lucie Rárová3, Jiří Grúz4, Karel Doležal5, Johannes Van Staden6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Leucosidea sericea is a southern African tree used for treating different diseases including microbial infections and inflammatory-related conditions. AIM OF THE STUDY: To isolate and identify the chemicals in Leucosidea sericea which possibly account for the diverse therapeutic effects of the species.
MATERIALS AND METHODS: Leaf material was extracted using 20% methanol and subsequently partitioned with different solvents (hexane, dichloromethane, ethyl acetate and butanol). Resultant fractions were subjected to bioactive (antimicrobial)-guided isolation and the structural elucidation was conducted using NMR (1D and 2D) spectroscopic methods. Given the broad uses of Leucosidea sericea in traditional medicine, the extract, fractions and isolated compounds were evaluated in five (5) biological assays in vitro (antimicrobial, antioxidant, acetylcholinesterase (AChE) and anti-inflammatory inhibition as well as cytotoxicity effect).
RESULTS: As the most active fractions, from ethyl acetate yielded 5,7-dihydroxychromone (1); 1-hydroxy-2-oxopomolic acid (2); 3,5,7,3´,4´-pentahydroxyflavone (3) and Tiliroside (4). For the first time, these four (4) compounds were isolated from leaves of Leucosidea sericea. These aforementioned compounds demonstrated broad-spectrum antibacterial activity (1.95-125 µg/mL) and noteworthy antifungal (3.9-250 µg/mL) potential. In addition to its noteworthy antimicrobial activity, compound 3 also demonstrated significant antioxidant (EC50 = 14 µg/mL in DPPH assay) and anti-inflammatory (inhibited the level of ELAM by approximately 36% and decreased also the viability of endothelial cells) activities in vitro. Overall, AChE inhibition activity and cytotoxic response was generally weak for the extracts, fractions and isolated compounds.
CONCLUSION: The pool of chemicals in Leucosidea sericea were enriched with the isolation and identification of four (4) compounds obtained from the leaf extract. Among these compounds, the significant antimicrobial activity of compound 3 provides strong evidence that support the use of Leucosidea sericea for microbial-related infections in folk medicine.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Antimicrobial; Antioxidants; Natural product; Phenolic acids; Rosaceae

Mesh:

Substances:

Year:  2018        PMID: 29604376     DOI: 10.1016/j.jep.2018.03.035

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Isolation, characterization and biological activities of betulin from Acacia nilotica bark.

Authors:  Prabhjit Kaur; Saroj Arora; Rajbir Singh
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

2.  Phytochemical Profiling and Isolation of Bioactive Compounds from Leucosidea sericea (Rosaceae).

Authors:  Tshifhiwa Ramabulana; Musawenkosi Ndlovu; Rebamang A Mosa; Molahlehi S Sonopo; Mamoalosi A Selepe
Journal:  ACS Omega       Date:  2022-03-31

3.  Anti-Pulmonary Fibrosis Activities of Triterpenoids from Oenothera biennis.

Authors:  Juanjuan Liu; Jingke Zhang; Mengnan Zeng; Meng Li; Shuangshuang Xie; Xiaoke Zheng; Weisheng Feng
Journal:  Molecules       Date:  2022-07-29       Impact factor: 4.927

4.  Green Synthesis of Gold Nanoparticles Capped with Procyanidins from Leucosidea sericea as Potential Antidiabetic and Antioxidant Agents.

Authors:  Umar M Badeggi; Enas Ismail; Adewale O Adeloye; Subelia Botha; Jelili A Badmus; Jeanine L Marnewick; Christopher N Cupido; Ahmed A Hussein
Journal:  Biomolecules       Date:  2020-03-13

5.  1H-NMR Metabolomics and LC-MS Analysis to Determine Seasonal Variation in a Cosmeceutical Plant Leucosidea sericea.

Authors:  Phophi Freda Sehlakgwe; Namrita Lall; Gerhard Prinsloo
Journal:  Front Pharmacol       Date:  2020-03-05       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.